anmelden
BX Swiss TOP 30 CHF
1.443,12
PKT
+15,69
PKT
+1,10
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 09.05.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 09.05.19 | Zurich Insurance Neutral | JP Morgan Chase & Co. | |
| 08.05.19 | Nestlé Sector Perform | RBC Capital Markets | |
| 08.05.19 | Nestlé overweight | Morgan Stanley | |
| 08.05.19 | Swiss Re buy | HSBC | |
| 08.05.19 | Nestlé overweight | JP Morgan Chase & Co. | |
| 08.05.19 | Roche overweight | JP Morgan Chase & Co. | |
| 07.05.19 | Novartis Hold | Deutsche Bank AG | |
| 07.05.19 | Swiss Re Hold | Deutsche Bank AG | |
| 07.05.19 | Roche Reduce | Oddo BHF | |
| 06.05.19 | Zurich Insurance Equal weight | Barclays Capital | |
| 06.05.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 03.05.19 | Swiss Re buy | Goldman Sachs Group Inc. | |
| 03.05.19 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 03.05.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 03.05.19 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 03.05.19 | Swiss Re Sector Perform | RBC Capital Markets | |
| 03.05.19 | Swiss Re Sell | UBS AG | |
| 02.05.19 | Holcim overweight | Morgan Stanley | |
| 02.05.19 | Holcim Sell | UBS AG | |
| 02.05.19 | UBS Equal weight | Barclays Capital | |
| 30.04.19 | Roche overweight | Morgan Stanley | |
| 30.04.19 | Swiss Re buy | Goldman Sachs Group Inc. | |
| 29.04.19 | UBS Sector Perform | RBC Capital Markets | |
| 29.04.19 | UBS Sector Perform | RBC Capital Markets | |
| 29.04.19 | Nestlé buy | Goldman Sachs Group Inc. | |
| 26.04.19 | UBS Hold | Kepler Cheuvreux | |
| 26.04.19 | UBS Outperform | Credit Suisse Group | |
| 26.04.19 | UBS buy | HSBC | |
| 25.04.19 | Novartis Neutral | Credit Suisse Group | |
| 25.04.19 | Novartis Hold | Deutsche Bank AG | |
| 25.04.19 | Novartis Hold | HSBC | |
| 25.04.19 | Novartis buy | Jefferies & Company Inc. | |
| 25.04.19 | UBS buy | UBS AG | |
| 25.04.19 | UBS Neutral | Goldman Sachs Group Inc. | |
| 25.04.19 | UBS Sector Perform | RBC Capital Markets | |
| 25.04.19 | UBS overweight | JP Morgan Chase & Co. | |
| 25.04.19 | UBS Hold | Deutsche Bank AG | |
| 25.04.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 24.04.19 | Novartis Conviction Buy List | Goldman Sachs Group Inc. |
